Multispecies biofilm behavior and host interaction support the association of Tannerella serpentiformis with periodontal health.

Tannerella species biofilm composition and architecture cell adhesion and invasion immunostimulatory potential multispecies model biofilm periodontitis

Journal

Molecular oral microbiology
ISSN: 2041-1014
Titre abrégé: Mol Oral Microbiol
Pays: Denmark
ID NLM: 101524770

Informations de publication

Date de publication:
04 2023
Historique:
revised: 15 07 2022
received: 13 06 2022
accepted: 09 08 2022
pubmed: 15 8 2022
medline: 22 3 2023
entrez: 14 8 2022
Statut: ppublish

Résumé

The recently identified bacterium Tannerella serpentiformis is the closest phylogenetic relative of Tannerella forsythia, whose presence in oral biofilms is associated with periodontitis. Conversely, T. serpentiformis is considered health-associated. This discrepancy was investigated in a comparative study of the two Tannerella species. The biofilm behavior was analyzed upon their addition and of Porphyromonas gingivalis-each bacterium separately or in combinations-to an in vitro five-species oral model biofilm. Biofilm composition and architecture was analyzed quantitatively using real-time PCR and qualitatively by fluorescence in situ hybridization/confocal laser scanning microscopy, and by scanning electron microscopy. The presence of T. serpentiformis led to a decrease of the total cell number of biofilm bacteria, while P. gingivalis was growth-promoting. This effect was mitigated by T. serpentiformis when added to the biofilm together with P. gingivalis. Notably, T. serpentiformis outcompeted T. forsythia numbers when the two species were simultaneously added to the biofilm compared to biofilms containing T. forsythia alone. Tannerella serpentiformis appeared evenly distributed throughout the multispecies biofilm, while T. forsythia was surface-located. Adhesion and invasion assays revealed that T. serpentiformis was significantly less effective in invading human gingival epithelial cells than T. forsythia. Furthermore, compared to T. forsythia, a higher immunostimulatory potential of human gingival fibroblasts and macrophages was revealed for T. serpentiformis, based on mRNA expression levels of the inflammatory mediators interleukin 6 (IL-6), IL-8, monocyte chemoattractant protein-1 and tumor necrosis factor α, and production of the corresponding proteins. Collectively, these data support the potential of T. serpentiformis to interfere with biological processes relevant to the establishment of periodontitis.

Identifiants

pubmed: 35964247
doi: 10.1111/omi.12385
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

115-133

Subventions

Organisme : Austrian Science Fund FWF
ID : P 33618
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 34642
Pays : Austria

Informations de copyright

© 2022 The Authors. Molecular Oral Microbiology published by John Wiley & Sons Ltd.

Références

Anal Biochem. 1990 May 15;187(1):147-50
pubmed: 2196831
Caries Res. 2006;40(2):163-71
pubmed: 16508276
Virulence. 2015;6(3):282-92
pubmed: 25831954
Front Microbiol. 2015 Apr 21;6:312
pubmed: 25954253
J Dent Res. 2008 Jun;87(6):558-63
pubmed: 18502965
PLoS One. 2016 Jan 14;11(1):e0146926
pubmed: 26764907
BMC Genomics. 2020 Feb 11;21(1):150
pubmed: 32046654
Front Microbiol. 2018 Jan 26;9:19
pubmed: 29434575
Int J Mol Sci. 2019 Jun 04;20(11):
pubmed: 31167516
PLoS One. 2013 Aug 26;8(8):e71727
pubmed: 23990979
PLoS One. 2017 Aug 3;12(8):e0182164
pubmed: 28771533
Immunol Lett. 2014 Dec;162(2 Pt A):22-38
pubmed: 25447398
Mol Oral Microbiol. 2012 Feb;27(1):11-22
pubmed: 22230462
Mediators Inflamm. 2019 Apr 23;2019:8127301
pubmed: 31178663
FEMS Microbiol Lett. 2018 Sep 1;365(17):
pubmed: 30052903
Microb Pathog. 2016 May;94:104-11
pubmed: 26806000
Microbiology (Reading). 2007 Nov;153(Pt 11):3809-3816
pubmed: 17975090
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
mSystems. 2018 Jun 5;3(3):
pubmed: 29896567
J Microbiol Methods. 2004 Jan;56(1):37-47
pubmed: 14706749
Int J Mol Sci. 2020 Dec 10;21(24):
pubmed: 33321934
Microbiology (Reading). 2011 Nov;157(Pt 11):3195-3202
pubmed: 21885482
Nat Rev Dis Primers. 2017 Jun 22;3:17038
pubmed: 28805207
J Clin Periodontol. 1998 Feb;25(2):134-44
pubmed: 9495612
Periodontol 2000. 2020 Oct;84(1):14-34
pubmed: 32844416
Front Immunol. 2020 Mar 31;11:511
pubmed: 32296429
J Clin Periodontol. 2012 Jul;39(7):617-25
pubmed: 22607053
J Periodontol. 2019 Oct;90(10):1190-1201
pubmed: 31049957
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
J Dent Res. 2016 Oct;95(11):1308-13
pubmed: 27193146
Mol Oral Microbiol. 2012 Dec;27(6):409-19
pubmed: 23134607
Infect Immun. 1983 Nov;42(2):459-70
pubmed: 6196291
Infect Immun. 1995 Oct;63(10):3878-85
pubmed: 7558295
J Mol Recognit. 2013 Nov;26(11):542-9
pubmed: 24089361
Front Microbiol. 2018 Aug 28;9:2008
pubmed: 30210478
Infect Immun. 2011 Jan;79(1):393-401
pubmed: 21078857
BMC Microbiol. 2012 Oct 05;12:227
pubmed: 23040057
Front Oral Health. 2021 Apr 16;2:648901
pubmed: 35048000
Periodontol 2000. 2020 Jun;83(1):26-39
pubmed: 32385877
J Endod. 2009 Jan;35(1):86-94
pubmed: 19084132
Curr Oral Health Rep. 2020 Mar;7(1):12-21
pubmed: 33344104
Arch Oral Biol. 2015 Sep;60(9):1387-93
pubmed: 26143497
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Mol Oral Microbiol. 2011 Aug;26(4):229-40
pubmed: 21729244
Proteomics Clin Appl. 2014 Oct;8(9-10):748-61
pubmed: 24828325
Mediators Inflamm. 2019 Jun 24;2019:7241312
pubmed: 31341421
Front Cell Infect Microbiol. 2022 Feb 10;12:835509
pubmed: 35223555
Sci Rep. 2017 Nov 17;7(1):15789
pubmed: 29150625
Glycobiology. 2017 Apr 1;27(4):342-357
pubmed: 27986835
Mol Oral Microbiol. 2018 Jun;33(3):234-239
pubmed: 29327482
Sci Adv. 2019 Jan 23;5(1):eaau3333
pubmed: 30746447
Nat Rev Microbiol. 2010 Jul;8(7):481-90
pubmed: 20514045
J Dent Res. 2018 Apr;97(4):371-380
pubmed: 29195050
J Clin Periodontol. 2017 Mar;44 Suppl 18:S12-S22
pubmed: 28266111
Trends Immunol. 2014 Jan;35(1):3-11
pubmed: 24269668
Mediators Inflamm. 2020 Jul 2;2020:8704896
pubmed: 32714091
J Periodontal Implant Sci. 2016 Feb;46(1):2-9
pubmed: 26937289
Microbiology (Reading). 2011 Aug;157(Pt 8):2382-2391
pubmed: 21622527
Mol Oral Microbiol. 2023 Apr;38(2):115-133
pubmed: 35964247
J Clin Periodontol. 2019 Jan;46(1):6-11
pubmed: 30556922
Int J Syst Evol Microbiol. 2020 Jun;70(6):3749-3754
pubmed: 32519941
Nat Rev Immunol. 2015 Jan;15(1):30-44
pubmed: 25534621
Infect Immun. 2008 Jan;76(1):198-205
pubmed: 17967853
PLoS One. 2017 Mar 6;12(3):e0173394
pubmed: 28264048
Microb Physiol. 2021;31(2):123-134
pubmed: 34107471
Curr Opin Immunol. 2002 Feb;14(1):103-10
pubmed: 11790539
Infect Immun. 1998 Dec;66(12):5703-10
pubmed: 9826345
J Dent Res. 2009 Aug;88(8):741-5
pubmed: 19734462
Periodontol 2000. 2021 Jun;86(1):57-78
pubmed: 33690899
J Dent Res. 2011 Jan;90(1):109-14
pubmed: 20929722
J Periodontol. 2022 Apr;93(4):515-525
pubmed: 34458990
Periodontol 2000. 2020 Jun;83(1):14-25
pubmed: 32385883
Microbiology (Reading). 2007 Mar;153(Pt 3):866-876
pubmed: 17322207
Trends Mol Med. 2015 Mar;21(3):172-83
pubmed: 25498392
Mucosal Immunol. 2013 Mar;6(2):415-26
pubmed: 22968422
J Biol Chem. 2011 Nov 4;286(44):38714-38724
pubmed: 21911490
Front Cell Infect Microbiol. 2019 Dec 18;9:432
pubmed: 31921707
Front Cell Infect Microbiol. 2017 Aug 04;7:351
pubmed: 28824884
Mol Oral Microbiol. 2018 Apr;33(2):155-167
pubmed: 29235255
Adv Immunol. 1994;55:97-179
pubmed: 8304236
Sci Rep. 2019 Apr 2;9(1):5491
pubmed: 30940882
J Dent Res. 2007 Apr;86(4):306-19
pubmed: 17384024
Interface Focus. 2019 Apr 6;9(2):20180064
pubmed: 30842870
Mol Oral Microbiol. 2017 Oct;32(5):404-418
pubmed: 28382776
Mol Immunol. 2011 Dec;49(3):423-32
pubmed: 22030478
BMC Microbiol. 2020 Nov 17;20(1):352
pubmed: 33203363
Oral Dis. 2022 Apr;28(3):777-785
pubmed: 33386669
Mol Oral Microbiol. 2015 Dec;30(6):451-73
pubmed: 25953484
Periodontol 2000. 2005;38:72-122
pubmed: 15853938
Cancer Res. 1991 May 15;51(10):2515-20
pubmed: 2021931
Arch Microbiol. 2012 Jun;194(6):525-39
pubmed: 22273979
Dent J (Basel). 2019 Dec 11;7(4):
pubmed: 31835888
Periodontol 2000. 2016 Oct;72(1):54-75
pubmed: 27501491
Arch Oral Biol. 2014 Sep;59(9):977-86
pubmed: 24949828
J Periodontal Res. 2013 Aug;48(4):517-26
pubmed: 23278531

Auteurs

Fabian L Kendlbacher (FL)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Susanne Bloch (S)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Fiona F Hager-Mair (FF)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Johanna Bacher (J)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Bettina Janesch (B)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Thomas Thurnheer (T)

Clinic of Conservative and Preventive Dentistry, Division of Clinical Oral Microbiology and Immunology, Center of Dental Medicine, University of Zürich, Zürich, Switzerland.

Oleh Andrukhov (O)

Competence Center for Periodontal Research, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.

Christina Schäffer (C)

NanoGlycobiology Unit, Department of NanoBiotechnology, Universität für Bodenkultur Wien, Vienna, Austria.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH